Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-01-26 @ 9:13 PM
Study NCT ID:
NCT00131118
Status:
COMPLETED
Last Update Posted:
2017-06-01
First Post:
2005-08-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-15
First Submit QC Date:
None
Study First Post Date:
2005-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-31
Last Update Post Date:
2017-06-01
Last Update Post Date Type:
ACTUAL